Terns Pharmaceuticals Inc (TERN)
8.27
+0.07
(+0.85%)
USD |
NASDAQ |
Oct 04, 16:00
8.28
+0.01
(+0.12%)
After-Hours: 20:00
Terns Pharmaceuticals Shareholders Equity (Annual): 255.37M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 255.37M |
| December 31, 2022 | 276.94M |
| December 31, 2021 | 160.30M |
| Date | Value |
|---|---|
| December 31, 2020 | 68.59M |
| December 31, 2019 | 4.207M |
| December 31, 2018 | 72.23M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
4.207M
Minimum
2019
276.94M
Maximum
2022
153.08M
Average
160.30M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Eli Lilly and Co | 10.77B |
| Biomarin Pharmaceutical Inc | 4.952B |
| ICU Medical Inc | 2.123B |
| Elite Pharmaceuticals Inc | 57.58M |
| Verrica Pharmaceuticals Inc | 19.76M |